Neurology Ionis Young Investigator Grant (YIG) supports early-career investigators conducting Angelman Syndrome research to advance disease understanding, early diagnosis, and patient care.
Funder: Ionis Pharmaceuticals
Due Dates (Anticipated): May 2027 (Application deadline)
Funding Amounts: $50,000 per year for up to two academic years; two investigators supported annually
Summary: Supports early-career investigators conducting innovative translational, clinical, or applied Angelman Syndrome research to advance disease understanding and patient care.
Key Information: Applicants must hold a doctoral degree during funding and have no more than four years of postdoctoral research experience at the application deadline.
The Neurology Ionis Young Investigator Grant is administered by the Neurology division within Medical Affairs at Ionis Pharmaceuticals. It supports high-quality, innovative translational, clinical, or applied research on Angelman Syndrome while developing future researchers and clinicians. Research priorities include advancing disease understanding, facilitating early diagnosis, characterizing disease across age groups and genetic subtypes, identifying undiagnosed or misdiagnosed patients, and improving patient care.
The program supports mentored research at academic or nonprofit institutions. Projects should broaden investigators’ postdoctoral research experience rather than extend preexisting, extensive postdoctoral training. Proposed work must be achievable within two years or less, with research data expected to be submitted for external presentation and/or publication within two years of initial funding.